FDA approves Sanofi's diabetes drug Toujeo

(Reuters) - U.S. health regulators on Wednesday approved Sanofi's diabetes drug Toujeo, a more potent follow-up to the French drugmaker's top-selling insulin product Lantus.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news